🇺🇸 FDA
Patent

US 12006355

Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)

granted A61KA61K31/166

Quick answer

US patent 12006355 (Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)) held by The Regents of the University of California expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/166